Brokers Watch List: Humana Inc (NYSE:HUM), Galena Biopharma Inc (NASDAQ:GALE), Spirit Realty Capital, Inc (New) (NYSE:SRC)

Humana Inc (NYSE:HUM) fall -9.58% during last trading as the stock added -$17.24 to finish the day at $162.74 with about 9.07M shares changing hands, compared to its three month average trading volume of 1.48M. The $ 24.63B market cap company, which fluctuated between $158.60 and $180.37 during the day, currently situated 5.17% above its 52 week low of $154.74 and -14.95% away from its one year high of $191.34. The RSI of 32.53 indicates the stock is overbought at the current levels, sell for now.

Humana Inc. is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Galena Biopharma Inc (NASDAQ:GALE) fall -$0.074 to close the day at a new closing price of $0.515, a -12.59% decrease in value from its previous closing price that moved the stock 83.79% above its 52 week low of $0.28. A total of 9.16M shares exchanged hands during the day compared with its three month average trading volume of 11.22M. The stock, which fluctuated between $0.51 and $0.58 during the day, currently situated -79.33% below its 52 week high. The stock is down by -74.52% in the past one month and down by -64.51% over the past three months. With a one year target estimate of $3.13 and RSI of 26.07, the stock still has upside potential, making it a hold for now.

Galena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company’s development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company’s NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies.

Spirit Realty Capital, Inc (New) (NYSE:SRC) had a light trading with around 9.25M shares changing hands compared to its three month average trading volume of 3.95M. The stock traded between $12.72 and $13.03 before closing at the price of $12.96 with -0.77% change on the day. The company is currently trading 55.82% above its 52 week low of $8.32 and -1.29% above its 52 week high of $13.13. Both the RSI indicator and target price of 75.43 and $12.23 respectively, lead us to believe that it could drop over the coming weeks.

Spirit Realty Capital, Inc is a publicly traded real estate investment trust. The firm primarily acquires across the United States single tenant operationally essential real estate, which refers to generally free-standing, commercial real estate facilities where tenants conduct retail, service or distribution activities that are essential to the generation of their sales and profits. The firm was formerly known as Spirit Finance Corp. Spirit Realty Capital, Inc was formed on August 14, 2003 and is domiciled in the United States.

Worth Watching Stocks: Western Digital (NASDAQ:WDC), Humana (NYSE:HUM), Philip Morris International (NYSE:PM)

Humana Inc (NYSE:HUM) fall -3.51% during last trading as the stock less -$6.33 to finish the day at $174.00 with about 4.78M shares changing hands, compared to its three month average trading volume of 1.45M. The $25.08B market cap company, which fluctuated between $169.98 and $181.21 during the day, currently situated 12.45% above its 52 week low of $154.74 and –10.19% away from its one year high of $193.74. The RSI of 38.31 indicates the stock is overbought at the current levels, sell for now. Humana Inc. is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Philip Morris International Inc. (NYSE:PM) fall -$0.44 to close the day at a new closing price of $101.28, a -0.43% decrease in value from its previous closing price that moved the stock 38.42% above its 52 week low of $73.17. A total of 4.76M shares exchanged hands during the day compared with its three month average trading volume of 4.39M. The stock, which fluctuated between $101.13 and $102.30 during the day, currently situated -0.62% below its 52 week high. The stock is up by 3.07 % in the past one month and up by 1.94 % over the past three months. With a one year target estimate of $103.60 and RSI of 58.03, the stock still has upside potential, making it a hold for now. Philip Morris International Inc. is a holding company engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States. The Company’s products are sold in over 180 markets. Its segments include European Union; Eastern Europe, Middle East & Africa; Asia, and Latin America & Canada. The Company’s premium price brands include Marlboro, Merit, Parliament and Virginia Slims; mid-price brands include L&M and Philip Morris, and other international brands include Bond Street, Chesterfield, Lark, Muratti, Next and Red & White. Its local cigarette brands consist of Dji Sam Soe, Sampoerna and U Mild in Indonesia; Champion, Fortune and Hope in the Philippines; Apollo-Soyuzand Optima in Russia; Morven Gold in Pakistan; Boston in Colombia, Belmont, Canadian Classics and Number 7 in Canada; Best in Serbia; f6 in Germany; Delicados in Mexico; Assos in Greece, and Petra in the Czech Republic and Slovakia.

Western Digital Corp (NASDAQ:WDC) had a light trading with around 4.76M shares changing hands compared to its three month average trading volume of 6.68M. The stock traded between $46.13 and $46.88 before closing at the price of $46.47 with -1.67% change on the day. The company is currently trading 34.33% above its 52 week low of $34.59 and -45.47% below its 52 week high of $85.22. Both the RSI indicator and target price of 52.77 and $58.10 respectively, lead us to believe that it could drop over the coming weeks.

Look Out For Analyst’s Recommendation: Humana Inc. (HUM)

The shares of Humana Inc. (NYSE:HUM) currently has mean rating of 2.50 while 3 analysts have recommended the shares as “BUY”, 3 recommended as “OUTPERFORM” and 12 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 13.62B by 13 analysts. The means estimate of sales for the year ending Dec-16 is 54.27B by 14 analysts.

The mean price target for the shares of Humana Inc. (HUM) is at 205.50 while the highest price target suggested by the analysts is 230.00 and low price target is 176.93. The mean price target is calculated keeping in view the consensus of 14 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Humana Inc. (HUM) stands at 2.19 while the EPS for the current year is fixed at 8.87 by 19 analysts.

The next one year’s EPS estimate is set at 10.03 by 22 analysts while a year ago the analysts suggested the company’s EPS at 8.87. The analysts also projected the company’s long-term growth at 13.93% for the upcoming five years.

In its latest quarter ended on 31st March 2016, Humana Inc. (HUM) reported earnings of $1.86. The posted earnings topped the analyst’s consensus by $0.05 with the surprise factor of 2.80%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Humana Inc. (HUM) will showcase its largest ever list of healthy food items through its signature Humana Healthier Choices program at Taste of Chicago 2016, the world’s largest food festival.

The Humana Healthier Choices – selected by a panel of physicians and nutrition experts based on calories, saturated fat, sodium and ingredients – allow Taste-goers to indulge in the foods they love without stressing over their health and well-being. This year’s Humana Healthier Choices list features 75 healthy food options – the most in the program’s nine-year history – from 29 Chicago restaurants, which represent 40 percent of the total restaurants participating at the year’s festival.